Research Institute

Epcoritamab for DLBCL or FL

Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma (Previously Grade 1-3a): Epcoritamab in Outpatient Setting

Disease Types: Lymphoma

Available at: Roanoke

Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma (Previously Grade 1-3a): Epcoritamab in Outpatient Setting

For More Information:

https://clinicaltrials.gov/study/NCT05451810?term=Relapsed%20or%20Refractory%20Diffuse%20Large%20B-Cell%20Lymphoma%20and%20Classic%20Follicular%20Lymphoma%20(Previously%20Grade%201-3a):%20Epcoritamab%20in%20Outpatient%20Setting&rank=1